Devices
FDA Clears Expanded Tactoset Indication
FDA has given an additional 510(k) clearance to Anika Therapeutics’ Tactoset injectable bone substitute. The company says the new indication expands the use of Tactoset to include augmentation of hardware and the support of bone fragments during surgical procedures. Anika describes Tactoset as a calcium phosphate-based, biocompatible bone